The information on this site is intended for US healthcare professionals and clinical staff only.
BOXED WARNING: FATAL AND SERIOUS TOXICITIES: HEPATIC, SEVERE DIARRHEA, COLITIS, PNEUMONITIS, INFECTIONS, AND INTESTINAL PERFORATION
*Safety data reflect exposure to ZYDELIG from 3 open-label clinical trials (Studies 101-09, 101-02, 101-10) in 146 patients with iNHL, including patients with follicular lymphoma and SLL.
†Diarrhea, abdominal pain, pneumonia, and rash include multiple preferred terms.
‡Includes patients of all iNHL histologies enrolled in Study 101-09 (N=125), not just patients with SLL.2
AE=adverse event; ALT=alanine aminotransferase; AST=aspartate aminotransferase; iNHL=indolent non-Hodgkin lymphoma; SLL=small lymphocytic lymphoma.